11-64804645-G-T

Variant names:

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. PP2BP6BS2

The NM_001370259.2(MEN1):c.1522C>A(p.Gln508Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000145 in 1,449,898 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q508E) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 34)

Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

MEN1
NM_001370259.2 missense

Scores

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 4.98

Publications

2 publications found

Variant links:

Genes affected

MEN1 (HGNC:7010): (menin 1) This gene encodes menin, a tumor suppressor associated with a syndrome known as multiple endocrine neoplasia type 1. Menin is a scaffold protein that functions in histone modification and epigenetic gene regulation. It is thought to regulate several pathways and processes by altering chromatin structure through the modification of histones. [provided by RefSeq, May 2019]

MEN1 Gene-Disease associations (from GenCC):

multiple endocrine neoplasia type 1
Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet, Ambry Genetics
familial isolated hyperparathyroidism
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
pituitary gigantism
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
hereditary pheochromocytoma-paraganglioma
Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

MEN1 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

PP2

Missense variant in the MEN1 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 113 curated pathogenic missense variants (we use a threshold of 10). The gene has 20 curated benign missense variants. Trascript score misZ: 4.1921 (above the threshold of 3.09). GenCC associations: The gene is linked to multiple endocrine neoplasia type 1, hereditary pheochromocytoma-paraganglioma, pituitary gigantism, familial isolated hyperparathyroidism.

BP6

Variant 11-64804645-G-T is Benign according to our data. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081. Variant chr11-64804645-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 403081.

BS2

High AC in GnomAdExome4 at 21 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
MEN1	NM_001370259.2 link	c.1522C>A	p.Gln508Lys	missense_variant	Exon 10 of 10	ENST00000450708.7	NP_001357188.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
MEN1	ENST00000450708.7 link	c.1522C>A	p.Gln508Lys	missense_variant	Exon 10 of 10	5	NM_001370259.2	ENSP00000394933.3		O00255-2

Frequencies

GnomAD3 genomes

Cov.:

GnomAD2 exomes

AF:

0.0000176

AC:

AN:

227726

AF XY:

0.0000160

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.00

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.0000295

Gnomad OTH exome

AF:

0.000176

GnomAD4 exome

AF:

0.0000145

AC:

AN:

1449898

Hom.:

Cov.:

AF XY:

0.00000971

AC XY:

AN XY:

720992

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

33236

American (AMR)

AF:

0.00

AC:

AN:

43818

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

25942

East Asian (EAS)

AF:

0.00

AC:

AN:

39462

South Asian (SAS)

AF:

0.00

AC:

AN:

85874

European-Finnish (FIN)

AF:

0.00

AC:

AN:

47354

Middle Eastern (MID)

AF:

0.00

AC:

AN:

5558

European-Non Finnish (NFE)

AF:

0.0000171

AC:

AN:

1108666

Other (OTH)

AF:

0.0000333

AC:

AN:

59988

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.508

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

Cov.:

Alfa

AF:

0.0000567

Hom.:

Bravo

AF:

0.0000189

ExAC

AF:

0.00000830

AC:

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Uncertain:2Benign:2

Revision: criteria provided, conflicting classifications

LINK: link

Submissions by phenotype

Multiple endocrine neoplasia, type 1

Uncertain:1Benign:1

Jan 22, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Feb 06, 2024

Baylor Genetics

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

not specified

Uncertain:1

Mar 29, 2016

Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Reported in 1 proband; ExAC: 1/51192 European chromosomes -

Hereditary cancer-predisposing syndrome

Benign:1

Nov 15, 2021

Ambry Genetics

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Benign

0.082

BayesDel_addAF

Pathogenic

0.21

BayesDel_noAF

Pathogenic

0.15

CADD

Benign

(source)

DANN

Benign

0.73

DEOGEN2

Benign

0.24

T;.;.;.;.;T;T;T;T

Eigen

Benign

-0.94

Eigen_PC

Benign

-0.82

FATHMM_MKL

Benign

0.40

LIST_S2

Benign

0.79

T;T;.;.;T;.;.;T;.

M_CAP

Pathogenic

0.85

MetaRNN

Uncertain

0.61

D;D;D;D;D;D;D;D;D

MetaSVM

Uncertain

0.12

MutationAssessor

Benign

0.69

.;.;.;.;.;N;N;N;N

PhyloP100

5.0

PrimateAI

Uncertain

0.63

PROVEAN

Benign

-0.43

N;N;N;N;N;N;N;N;N

REVEL

Uncertain

0.55

Sift

Benign

0.75

T;T;T;T;T;T;T;T;T

Sift4G

Benign

0.77

T;T;T;T;T;T;T;T;T

Polyphen

0.0040, 0.0050

.;B;B;B;B;B;B;B;B

Vest4

0.36

MutPred

0.77

.;.;.;.;.;Gain of glycosylation at Q513 (P = 0.0095);Gain of glycosylation at Q513 (P = 0.0095);Gain of glycosylation at Q513 (P = 0.0095);Gain of glycosylation at Q513 (P = 0.0095);

MVP

1.0

MPC

2.3

ClinPred

0.052

GERP RS

4.1

Varity_R

0.22

gMVP

0.71

Mutation Taster

=0/100

disease causing

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over